Director/PDMR Shareholding

RNS Number : 6193C

GlaxoSmithKline PLC

17 April 2013

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline UK and US Performance Share Plans notified the Company and the under-mentioned persons on 17 April 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.

	Ordinary Shares	ADSs
Sir Andrew Witty	14,975.978
Dr M M Slaoui		4,845.673
Mr S Dingemans	5,490.762
Mr S M Bicknell	1,624.186
Mr R G Connor	325.598
Mrs D P Connelly		2,058.731
Mr S A Hussain	4,136.092
Mr W C Louv		1,408.343
Mr D S Redfern	2,276.538
Ms C Thomas	3,143.972
Mr P C Thomson	800.315
Mr D E Troy		2,603.915
Dr P J T Vallance	4,589.736
Ms E Walmsley	2,596.317
Mr C Weber	488.564
Mrs V A Whyte	353.160

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

17 April 2013

 

END

 

 

RDSQDLFFXZFFBBZ